{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:37:17Z","timestamp":1787668637986,"version":"build-2736575974"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Preventing preeclampsia (PE) is crucial for the wellbeing of the mother, fetus, and the neonate with three levels: primary, secondary, and tertiary. Secondary prevention involves pharmacological therapies aimed at stopping the disease\u2019s progression before clinical signs. The predominant approach currently employed is the daily administration of low dose Aspirin and calcium. PE is a multifaceted illness characterized by syncytiotrophoblast (STB) stress, leading to endothelial dysfunction and systemic inflammation. Various subtypes of PE, in particular early-onset PE (EOP) and late-onset PE (LOP), have different pathophysiological pathways leading to STB stress and also different perinatal outcomes. Low-dose Aspirin (LDA) has been shown to be beneficial in lowering the occurrence of EOP, especially when started before 16\u00a0weeks of pregnancy. Calcium supplementation is advantageous for women with poor dietary calcium intake, reducing endothelium activation and hypertension. Low molecular weight heparins (LMWH), have pleiotropic effects, besides their anticoagulant effects, LMWH have significant anti-inflammatory effects, and have a potential restricted use in patients with history of prior severe placental vasculopathy with or without the maternal preeclamptic syndrome. Pravastatin and other statins have shown positive results in lowering preterm PE and improving outcomes for both the mother and baby. Proton pump inhibitors (PPIs) have shown potential in lowering soluble FMS-like tyrosine kinase-1 (sFlt-1) levels and enhancing endothelial function, but clinical trials have been inconsistent. Metformin, primarily used for improving insulin sensitivity, has potential advantages in decreasing PE incidence due to its anti-inflammatory and vascular properties, particularly in morbidly obese women. Nitric oxide (NO) donors and L-arginine have been shown to effectively reduce vascular resistance and improving blood flow to placenta, potentially reducing PE risk. In conclusion, various pharmacological treatments have the potential to prevent secondary PE, but their effectiveness depends on underlying risk factors and intervention time. Further research is needed to determine the optimal (combination) of method(s) for the individual patient with her individual risk profile.<\/jats:p>","DOI":"10.3389\/fcell.2025.1520218","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T06:51:53Z","timestamp":1738911113000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Secondary prevention of preeclampsia"],"prefix":"10.3389","volume":"13","author":[{"given":"Muhammad Ilham","family":"Aldika Akbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roudhona","family":"Rosaudyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanisyah Erza","family":"Gumilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Shanmugalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustaaf","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1111\/bph.12977","article-title":"Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm?","volume":"172","author":"Ahmed","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5468\/OGS.22261","article-title":"Preeclampsia and aspirin","volume":"66","author":"Ahn","year":"2023","journal-title":"Obstet. Gynecol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1055\/a-1798-1925","article-title":"INOVASIA study: a multicenter randomized clinical trial of pravastatin to prevent preeclampsia in high-risk patients","volume":"41","author":"Akbar","year":"2022","journal-title":"Am. J. Perinatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.56499\/jppres23.1791_12.3.573","article-title":"Role of pravastatin in the prevention of preeclampsia: a systematic review and meta-analysis of randomized-controlled trials","volume":"12","author":"Akbar","year":"2024","journal-title":"J. Pharm. Pharmacogn. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1080\/14767058.2021.1879785","article-title":"Pravastatin suppresses inflammatory cytokines and endothelial activation in patients at risk of developing preeclampsia: INOVASIA study","volume":"35","author":"Akbar","year":"","journal-title":"J. Maternal-Fetal Neonatal Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1055\/a-1673-5603","article-title":"INOVASIA study: a randomized open controlled trial to evaluate pravastatin to prevent preeclampsia and its effects on sFlt1\/PlGF levels","volume":"41","author":"Akbar","year":"","journal-title":"Am. J. Perinatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"102343","DOI":"10.1016\/J.EUJIM.2024.102343","article-title":"The effect of vitamin D supplementation in pregnancy on the incidence of preeclampsia: a systematic review and meta-analysis","volume":"66","author":"Alimoradi","year":"2024","journal-title":"Eur. J. Integr. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"20503121231212093","DOI":"10.1177\/20503121231212093","article-title":"Vitamin D and preeclampsia: a systematic review and meta-analysis","volume":"11","author":"AlSubai","year":"2023","journal-title":"SAGE Open Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1875692117666181207120011","article-title":"Oxidative stress as a key signaling pathway in placental angiogenesis changes oxidative stress as a key signaling pathway in placental angiogenesis changes in preeclampsia: updates in pathogenesis, novel biomarkers and therapeutics","volume":"16","author":"Anto","year":"2018","journal-title":"Curr. Pharmacogenomics Person. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1182\/BLOOD-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1210\/JC.2007-0718","article-title":"Maternal vitamin D deficiency increases the risk of preeclampsia","volume":"92","author":"Bodnar","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1038\/s41440-023-01323-w","article-title":"Preeclampsia up to date\u2014what\u2019s going on?","volume":"46","author":"Bokuda","year":"2023","journal-title":"Hypertens. Res."},{"key":"B14","first-page":"85","article-title":"The role of coagulation and fibrinolysis in preeclampsia","volume":"5","author":"Bonnar","year":"1976","journal-title":"Perspect. Nephrol. Hypertens."},{"key":"B15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/UOG.20722","article-title":"OP08.05: aspirin 100mg versus 150mg in pregnancy at high risk for pre-eclampsia","volume":"54","author":"Brito","year":"2019","journal-title":"Ultrasound Obstetrics and Gynecol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"102481","DOI":"10.1016\/J.BPOBGYN.2024.102481","article-title":"Prevention of preeclampsia","volume":"93","author":"Brownfoot","year":"2024","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"356.e1","DOI":"10.1016\/j.ajog.2015.12.019","article-title":"Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction","volume":"214","author":"Brownfoot","year":"","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"key":"B19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12884-016-0902-3","article-title":"Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta","volume":"16","author":"Brownfoot","year":"","journal-title":"BMC Pregnancy Childbirth"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/10641955.2015.1137586","article-title":"Efficacy of L-arginine for preventing preeclampsia in high-risk pregnancies: a double-blind, randomized, clinical trial","volume":"35","author":"Camarena Pulido","year":"2016","journal-title":"Hypertens. Pregnancy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.3390\/IJERPH20042994","article-title":"Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition","volume":"20","author":"Chang","year":"","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.3390\/ijerph20042994","article-title":"Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition","volume":"20","author":"Chang","year":"","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/S12884-016-1009-6","article-title":"Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"B25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","article-title":"Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial","volume":"3","author":"Chiswick","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/J.AMEPRE.2021.01.032","article-title":"Aspirin prophylaxis during pregnancy: a systematic review and meta-analysis","volume":"61","author":"Choi","year":"2021","journal-title":"Am. J. Prev. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"720.e1","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S1126","DOI":"10.1016\/j.ajog.2020.11.006","article-title":"Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis","volume":"226","author":"Cruz-Lemini","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.PLACENTA.2020.08.022","article-title":"Novel approaches to combat preeclampsia: from new drugs to innovative delivery","volume":"102","author":"de Alwis","year":"2020","journal-title":"Placenta"},{"key":"B31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0140-6736(00)03599-6","article-title":"Primary, secondary, and tertiary prevention of pre-eclampsia","volume":"357","author":"Dekker","year":"2001","journal-title":"Lancet"},{"key":"B32","volume-title":"Prediction and prevention of pregnancy-induced hypertensive disorders: a clinical and pathophysiologic study","author":"Dekker","year":"1989"},{"key":"B33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.37349\/EI.2021.00022","article-title":"Preeclampsiaan immune disease? An epidemiologic narrative","volume":"1","author":"Dekker","year":"2021","journal-title":"Open Explor."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0002-9378(98)70160-7","article-title":"Etiology and pathogenesis of preeclampsia: current concepts","volume":"179","author":"Dekker","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.3390\/ijms20112757","article-title":"The role of Nitric Oxide, ADMA, and Homocysteine in the etiopathogenesis of preeclampsia\u2014review","volume":"20","author":"Dymara-Konopka","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0003","DOI":"10.5041\/RMMJ.10426","article-title":"Different chemical structures and physiological\/pathological roles of cyclooxygenases","volume":"12","author":"Faki","year":"2021","journal-title":"Rambam Maimonides Med. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/EURHEARTJ\/EHR304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2011","journal-title":"Eur. Heart J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"101000","DOI":"10.1016\/J.AJOGMF.2023.101000","article-title":"Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis","author":"Ghesquiere","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jri.2017.09.009","article-title":"Pravastatin to treat and prevent preeclampsia. Preclinical and clinical studies","volume":"124","author":"Girardi","year":"2017","journal-title":"J. Reprod. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"22748","DOI":"10.1038\/s41598-021-02182-6","article-title":"Effects of prenatal oral l-arginine on birth outcomes: a meta-analysis","volume":"11","author":"Goto","year":"","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"22748","DOI":"10.1038\/S41598-021-02182-6","article-title":"Effects of prenatal oral L-arginine on birth outcomes: a meta-analysis","volume":"11","author":"Goto","year":"","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12884-016-1162-y","article-title":"Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomised trial (the EPPI trial): study protocol","volume":"16","author":"Groom","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"B43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00441-022-03587-z","article-title":"Esomeprazole inhibits hypoxia\/endothelial dysfunction\u2013induced autophagy in preeclampsia","volume":"388","author":"Gu","year":"2022","journal-title":"Cell. Tissue Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/AOG.0000000000001673","article-title":"Enoxaparin and aspirin compared with aspirin alone to prevent placenta-mediated pregnancy complications: a randomized controlled trial","volume":"128","author":"Haddad","year":"2016","journal-title":"Obstetrics Gynecol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/HYPERTENSIONAHA.118.12547","article-title":"Proton pump inhibitors and preeclampsia risk among 157 720 women: a Swedish population register-based cohort study","volume":"73","author":"Hastie","year":"2019","journal-title":"Hypertension"},{"key":"B46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.placenta.2023.10.003","article-title":"Protective role of metformin in preeclampsia via the regulation of NF-\u03baB\/sFlt-1 and Nrf2\/HO-1 signaling pathways by activating AMPK","volume":"143","author":"He","year":"2023","journal-title":"Placenta"},{"key":"B47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0140-6736(18)31818-X","article-title":"Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"393","author":"Hofmeyr","year":"2019","journal-title":"Lancet"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd001059.pub5","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems","volume":"2018","author":"Hofmeyr","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.3390\/jcm11164675","article-title":"Proton pump inhibitors use and risk of preeclampsia: a meta-analysis","volume":"11","author":"Hussain","year":"2022","journal-title":"J. Clin. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7860\/JCDR\/2019\/39924.12667","article-title":"Serum calcium and 25-hydroxy vitamin D level in normal and early onset pre-eclamptic pregnant women: a study from Indonesia","volume":"13","author":"Ilham","year":"2019","journal-title":"J. Clin. Diagnostic Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/J.PREGHY.2021.07.275","article-title":"SY6-2. Possible role of statin to prevent preeclampsia","volume":"25","author":"Ilham Aldika Akbar","year":"2021","journal-title":"Pregnancy Hypertens."},{"key":"B52","doi-asserted-by":"publisher","first-page":"102217","DOI":"10.1016\/J.CPCARDIOL.2023.102217","article-title":"Association between calcium supplementation and gestational hypertension, and preeclampsia: a Meta-analysis of 26 randomized controlled trials","volume":"49","author":"Jaiswal","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/BCP.12301","article-title":"The nitric oxide pathway and possible therapeutic options in pre-eclampsia","volume":"78","author":"Johal","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/UOG.19084","article-title":"Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials","volume":"52","author":"Kalafat","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fphar.2017.00247","article-title":"The role of statins in prevention of preeclampsia: a promise for the future?","volume":"8","author":"Katsi","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/0306-9877(95)90205-8","article-title":"Calcium supplementation prevents pregnancy-induced hypertension by increasing the production of vascular nitric oxide","volume":"45","author":"L\u00f3pez-Jaramillo","year":"1995","journal-title":"Med. Hypotheses"},{"key":"B57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis and management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"B58","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/BIOLOGICS1020015","article-title":"Implications of endothelial cell-mediated dysfunctions in vasomotor tone regulation","volume":"1","author":"Mangana","year":"2021","journal-title":"Biologics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/S10620-011-1940-3","article-title":"The safety of fetal exposure to proton-pump inhibitors during pregnancy","volume":"57","author":"Matok","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.3390\/ijms16034600","article-title":"Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia","volume":"16","author":"Matsubara","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1R","DOI":"10.1203\/01.PDR.0000159567.85157.B7","article-title":"Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia","volume":"57","author":"Maynard","year":"2005","journal-title":"Pediatr. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12916-022-02582-z","article-title":"Systematic evaluation of the pre-eclampsia drugs, dietary supplements and biologicals pipeline using target product profiles","volume":"20","author":"McDougall","year":"2022","journal-title":"BMC Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/BCP.13483","article-title":"Low molecular weight heparin for the prevention of severe preeclampsia: where next?","volume":"84","author":"McLaughlin","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"CD006490","DOI":"10.1002\/14651858.CD006490","article-title":"Nitric oxide for preventing pre-eclampsia and its complications","volume":"2007","author":"Meher","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.3390\/JCM12186020","article-title":"Recent advances in the prevention and screening of preeclampsia","volume":"12","author":"M\u00e9sz\u00e1ros","year":"","journal-title":"J. Clin. Med."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1076372","article-title":"Pravastatin in preeclampsia: a meta-analysis and systematic review","volume":"9","author":"M\u00e9sz\u00e1ros","year":"","journal-title":"Front. Med. (Lausanne)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/BCPT.13308","article-title":"Aspirin for the prevention and treatment of pre-eclampsia: a matter of COX-1 and\/or COX-2 inhibition?","volume":"127","author":"Mirabito Colafella","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1079\/BJN19900063","article-title":"A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial","volume":"64","author":"Olsen","year":"1990","journal-title":"Br. J. Nutr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3945\/AN.115.010736","article-title":"Calcium supplementation to prevent preeclampsia: translating guidelines into practice in low-income countries","volume":"7","author":"Omotayo","year":"2016","journal-title":"Adv. Nutr."},{"key":"B70","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008873","article-title":"Vitamin D supplementation for women during pregnancy","volume":"2019","author":"Palacios","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2215\/CJN.12081115","article-title":"Preeclampsia: updates in pathogenesis, definitions, and guidelines","volume":"11","author":"Phipps","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3390\/jcm10132805","article-title":"Prevention of hypertensive disorders of pregnancy\u2014is there a place for metformin?","volume":"10","author":"Poniedzia\u0142ek-Czajkowska","year":"2021","journal-title":"J. Clin. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/pd.4397","article-title":"First-trimester maternal factors and biomarker screening for preeclampsia","volume":"34","author":"Poon","year":"2014","journal-title":"Prenat. Diagn"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre\u2010eclampsia: a pragmatic guide for first\u2010trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynecol. and Obstetrics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12884-017-1408-3","article-title":"The role of vitamin D in pre-eclampsia: a systematic review","volume":"17","author":"Purswani","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"B78","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/J.JTUMED.2017.06.002","article-title":"Effect of a black cumin (Nigella sativa) ethanol extract on placental angiotensin II type 1-receptor autoantibody (AT1-AA) serum levels and endothelin-1 (ET-1) expression in a preeclampsia mouse model","volume":"12","author":"Rahma","year":"2017","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jri.2013.12.120","article-title":"Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia","author":"Ramma","year":"2014","journal-title":"J. Reprod. Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/J.PREGHY.2014.04.009","article-title":"Pre-eclampsia: a complex and variable disease","volume":"4","author":"Redman","year":"2014","journal-title":"Pregnancy Hypertens."},{"key":"B81","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.preghy.2016.10.011","article-title":"Early and late onset preeclampsia: two sides of the same coin","volume":"7","author":"Redman","year":"2017","journal-title":"Int. J. Women\u2019s Cardiovasc. Health"},{"key":"B82","doi-asserted-by":"publisher","first-page":"S907","DOI":"10.1016\/J.AJOG.2020.09.047","article-title":"Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways","volume":"226","author":"Redman","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/UOG.15789","article-title":"Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis","volume":"47","author":"Roberge","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/J.PLACENTA.2017.07.012","article-title":"Global Pregnancy Collaboration symposium: prepregnancy and very early pregnancy antecedents of adverse pregnancy outcomes: overview and recommendations","volume":"60","author":"Roberts","year":"2017","journal-title":"Placenta"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e0223888","DOI":"10.1371\/JOURNAL.PONE.0223888","article-title":"Increased BMI has a linear association with late-onset preeclampsia: a population-based study","volume":"14","author":"Robillard","year":"2019","journal-title":"PLoS One"},{"key":"B87","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1182\/ASHEDUCATION-2014.1.387","article-title":"Pregnancy and venous thromboembolism: \u201cTIPPS\u201d for risk stratification","volume":"2014","author":"Rodger","year":"2014","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"B89","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1933719113492207","article-title":"Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia","volume":"21","author":"Saad","year":"2014","journal-title":"Reprod. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4103\/2305-0500.331261","article-title":"Effects of L-arginine on preeclampsia risks and maternal and neonatal outcomes: a systematic review and meta-analysis","volume":"10","author":"Sagadevan","year":"2021","journal-title":"Asian Pac. J. Reproduction"},{"key":"B92","doi-asserted-by":"publisher","first-page":"12100","DOI":"10.3390\/IJMS241512100","article-title":"New ideas for the prevention and treatment of preeclampsia and their molecular inspirations","volume":"24","author":"Sakowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.117.09741","article-title":"Low soluble fms-like tyrosine kinase-1, endoglin, and endothelin-1 levels in women with confirmed or suspected preeclampsia using proton pump inhibitors","volume":"70","author":"Saleh","year":"2017","journal-title":"Hypertension"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41371-018-0113-7","article-title":"Aspirin in the prevention of preeclampsia: the conundrum of how, who and when","volume":"33","author":"Shanmugalingam","year":"","journal-title":"J. Hum. Hypertens."},{"key":"B95","doi-asserted-by":"publisher","first-page":"dgaa642","DOI":"10.1210\/CLINEM\/DGAA642","article-title":"The 15-epilipoxin-A4 pathway with prophylactic aspirin in preventing preeclampsia: a longitudinal cohort study","volume":"105","author":"Shanmugalingam","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B96","doi-asserted-by":"publisher","first-page":"255.e1","DOI":"10.1016\/J.AJOG.2019.04.027","article-title":"A pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy","volume":"221","author":"Shanmugalingam","year":"","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/UOG.23668","article-title":"ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis","volume":"58","author":"Shen","year":"2021","journal-title":"Ultrasound Obstetrics Gynecol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The national Institute of child health and human development network of maternal-fetal medicine units","volume":"329","author":"Sibai","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1182\/BLOODADVANCES.2023011895","article-title":"LMWH prevents thromboinflammation in the placenta via\u00a0HBEGF-AKT signaling","volume":"8","author":"Singh","year":"2024","journal-title":"Blood Adv."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e39752","DOI":"10.7759\/CUREUS.39752","article-title":"A randomized controlled study comparing the efficacy of 75mg versus 150mg aspirin for the prevention of preeclampsia in high-risk pregnant women","volume":"15","author":"Sinha","year":"2023","journal-title":"Cureus"},{"key":"B101","first-page":"157","article-title":"The differences between early- and late-onset pre-eclampsia","volume-title":"Preeclampsia","author":"Staff","year":""},{"key":"B102","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-981-10-5891-2_10","article-title":"The differences between early- and late-onset pre-eclampsia","author":"Staff","year":""},{"key":"B103","doi-asserted-by":"publisher","first-page":"62","DOI":"10.29309\/TPMJ\/2022.29.01.5613","article-title":"Role of l-arginine in the prevention of pre eclampsia in high-risk pregnancies","volume":"29","author":"Taj","year":"2022","journal-title":"Prof. Med. J."},{"key":"B104","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.1038\/s41598-021-88650-5","article-title":"Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review\/meta-analysis","volume":"11","author":"Tarry-Adkins","year":"2021","journal-title":"Sci. Rep."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3251956","DOI":"10.1155\/2020\/3251956","article-title":"Altered bioavailability of nitric oxide and L-arginine is a key determinant of endothelial dysfunction in preeclampsia","volume":"2020","author":"Tashie","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"B106","doi-asserted-by":"publisher","first-page":"S1157","DOI":"10.1016\/J.AJOG.2020.09.014","article-title":"Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia","volume":"226","author":"Tong","year":"","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"S1157","DOI":"10.1016\/j.ajog.2020.09.014","article-title":"Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia","volume":"226","author":"Tong","year":"","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"d2901","DOI":"10.1136\/BMJ.D2901","article-title":"Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial","volume":"342","author":"Vadillo-Ortega","year":"2011","journal-title":"BMJ"},{"key":"B109","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.preghy.2020.11.014","article-title":"Effects of statins on preeclampsia: a systematic review","volume":"23","author":"Vahedian-Azimi","year":"2021","journal-title":"Pregnancy Hypertens."},{"key":"B110","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/HYPERTENSIONAHA.108.117358","article-title":"Early and Late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease","volume":"52","author":"Valensise","year":"2008","journal-title":"Hypertension"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2147\/CLEP.S382303","article-title":"Associations between late-onset preeclampsia and the use of calcium-based antacids and proton pump inhibitors during pregnancy: a prospective cohort study","volume":"14","author":"van Gelder","year":"2022","journal-title":"Clin. Epidemiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"e30039","DOI":"10.7759\/cureus.30039","article-title":"A review on the use of metformin in pregnancy and its associated fetal outcomes","volume":"14","author":"Verma","year":"2022","journal-title":"Cureus"},{"key":"B113","doi-asserted-by":"publisher","first-page":"S224","DOI":"10.1016\/j.gaceta.2021.10.026","article-title":"Analysis of serum levels L-arginine and 25-hydroxyvitamin D as a predictor of survival of severe preeclampsia mothers","volume":"35","author":"Wahyuningsih","year":"2021","journal-title":"Gac. Sanit."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(86)91891-X","article-title":"Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravida","volume":"1","author":"Wallenburg","year":"1986","journal-title":"Lancet"},{"key":"B115","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.3390\/IJMS22136985","article-title":"The road to low-dose aspirin therapy for the prevention of preeclampsia began with the placenta","volume":"22","author":"Walsh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15296\/ijwhr.2021.06","article-title":"L-arginine protective effect on systemic blood pressure and placental expression of endoglin, transforming growth factor-\u03b21 in the preeclampsia mice model","volume":"9","author":"Wardhana","year":"2021","journal-title":"Int. J. Women\u2019s Health Reproduction Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/JTH.14191","article-title":"Molecular actions of heparin and their implications in preventing pre\u2010eclampsia","volume":"16","author":"Wat","year":"","journal-title":"J. Thrombosis Haemostasis"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/JTH.14191","article-title":"Molecular actions of heparin and their implications in preventing pre-eclampsia","volume":"16","author":"Wat","year":"","journal-title":"J. Thromb. Haemost."},{"key":"B119","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/advances\/nmz015","article-title":"Perspective: L-arginine and L-citrulline supplementation in pregnancy: a potential strategy to improve birth outcomes in low-resource settings","volume":"10","author":"Weckman","year":"2019","journal-title":"Adv. Nutr."},{"key":"B120","unstructured":"WHO recommendation: calcium supplementation during pregnancy for the prevention of pre-eclampsia and its complications - PubMed\n          \n          \n          2018"},{"key":"B121","unstructured":"WHO recommendation on calcium supplementation before pregnancy for the prevention of pre-eclampsia and its complications\n          \n          \n          2024"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1111\/1471-0528.17222","article-title":"Calcium for pre-eclampsia prevention: a systematic review and network meta-analysis to guide personalised antenatal care","volume":"129","author":"Woo Kinshella","year":"2022","journal-title":"BJOG"},{"key":"B123","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of preeclampsia","volume":"5","author":"Young","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/S43032-021-00678-0","article-title":"Low molecular weight heparins (LMWH) and implications along pregnancy: a focus on the placenta","volume":"29","author":"Zullino","year":"2021","journal-title":"Reprod. Sci."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1520218\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T06:51:59Z","timestamp":1738911119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1520218\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":124,"alternative-id":["10.3389\/fcell.2025.1520218"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1520218","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"article-number":"1520218"}}